Covestor’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Other funds holding URGN
KCM
ACA
OM
Covestor's URGN Position: Q3 2026 in Review
Covestor reduced its UroGen Pharma (URGN) stake by 43% in Q3 2026, selling an estimated $257 and leaving 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2858.
Covestor first reported a position in URGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $1K in Q2 2026. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.
- Covestor held 8 shares of UroGen Pharma worth $0 as of Q3 2026.
- Covestor sold 6 UroGen Pharma shares in Q3 2026, an estimated $257.
- UroGen Pharma made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2858 holding.
- Covestor first reported a position in UroGen Pharma in Q3 2025 and has held it in 4 quarters since.
- Covestor's UroGen Pharma position peaked at $1K in Q2 2026.
- 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.